PortfoliosLab logoPortfoliosLab logo
K vs. CVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

K vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kellogg Company (K) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


K

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

CVS

1D
1.47%
1M
3.92%
YTD
30.67%
6M
30.57%
1Y
59.29%
3Y*
16.60%
5Y*
7.08%
10Y*
3.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

K vs. CVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
K
Kellogg Company
0.00%5.99%49.75%-7.44%14.35%7.44%-6.78%26.08%-13.32%-4.93%
CVS
CVS Health Corporation
30.67%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%

Correlation

The correlation between K and CVS is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Dec 17, 1984

0.25

The correlation between K and CVS shifts across timeframes, from 0.06 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

K:

$29.20B

CVS:

$130.41B

EPS

K:

$3.65

CVS:

$2.30

PE Ratio

K:

22.87

CVS:

44.29

PS Ratio

K:

2.30

CVS:

0.32

PB Ratio

K:

6.95

CVS:

1.68

Total Revenue (TTM)

K:

$12.67B

CVS:

$407.91B

Gross Profit (TTM)

K:

$4.41B

CVS:

$56.59B

EBITDA (TTM)

K:

$2.25B

CVS:

$9.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

K vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

K

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


CVS
CVS Risk / Return Rank: 8686
Overall Rank
CVS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 8282
Sortino Ratio Rank
CVS Omega Ratio Rank: 8787
Omega Ratio Rank
CVS Calmar Ratio Rank: 8888
Calmar Ratio Rank
CVS Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

K vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kellogg Company (K) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KCVSDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.35

Calmar ratioReturn relative to maximum drawdown

3.62

Martin ratioReturn relative to average drawdown

9.33

K vs. CVS - Sharpe Ratio Comparison


Loading charts...

Drawdowns

K vs. CVS - Drawdown Comparison


Loading charts...

Drawdown Indicators


KCVSDifference

Max Drawdown

Largest peak-to-trough decline

-64.07%

Max Drawdown (1Y)

Largest decline over 1 year

-16.44%

Max Drawdown (3Y)

Largest decline over 3 years

-43.98%

Max Drawdown (5Y)

Largest decline over 5 years

-56.79%

Max Drawdown (10Y)

Largest decline over 10 years

-56.79%

Current Drawdown

Current decline from peak

0.00%

Average Drawdown

Average peak-to-trough decline

-19.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.38%

Volatility

K vs. CVS - Volatility Comparison


Loading charts...

Volatility by Period


KCVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.50%

Volatility (6M)

Calculated over the trailing 6-month period

25.88%

Volatility (1Y)

Calculated over the trailing 1-year period

31.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.30%

Dividends

K vs. CVS - Dividend Comparison

K has not paid dividends to shareholders, while CVS's dividend yield for the trailing twelve months is around 2.61%.


PositionTTM20252024202320222021202020192018201720162015
CVS
CVS Health Corporation
2.61%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%
K
Kellogg Company
1.39%2.76%2.79%10.56%3.28%3.59%3.66%3.27%3.86%3.12%2.77%2.74%

Financials

K vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between Kellogg Company and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
3.26B
100.43B
(K) Total Revenue
(CVS) Total Revenue
Values in USD except per share items

K vs. CVS - Profitability Comparison

The chart below illustrates the profitability comparison between Kellogg Company and CVS Health Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

15.0%20.0%25.0%30.0%35.0%20222023202420252026
33.3%
15.6%
Portfolio components
K - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kellogg Company reported a gross profit of 1.08B and revenue of 3.26B. Therefore, the gross margin over that period was 33.3%.

CVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.

K - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kellogg Company reported an operating income of 452.00M and revenue of 3.26B, resulting in an operating margin of 13.9%.

CVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.

K - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kellogg Company reported a net income of 309.00M and revenue of 3.26B, resulting in a net margin of 9.5%.

CVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.


Frequently Asked Questions


K and CVS have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for K and CVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer